The MYO9B Gene Is a Strong Risk Factor for Developing Refractory Celiac Disease

Clinical Gastroenterology and Hepatology

Volumn 5, Issue 12, 2007, Pages

  Wolters, Victorien M ^a   Verbeek, Wieke H M ^b   Zhernakova, Alexandra ^a   Onland Moret, Charlotte ^a   Schreurs, Marco W J ^b   Monsuur, Alienke J ^a   Verduijn, Willem ^c   Wijmenga, Cisca ^d   Mulder, Chris J J ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CLADRIBINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; CELIAC DISEASE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; ENTEROPATHY; GENE; GENE FREQUENCY; GENE INTERACTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MYO9B GENE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; T CELL LYMPHOMA;

EID: 36549070081     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2007.08.018     Document Type: Article

References (57)

1. Kagnoff M.F. Celiac disease: a gastrointestinal disease with environmental, genetic, and immunologic components. Gastroenterol Clin North Am 21 (1992) 405-425
2. Sollid L.M., Markussen G., Ek J., et al. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 169 (1989) 345-350
3. Kagnoff M.F. Overview and pathogenesis of celiac disease. Gastroenterology 128 Suppl 1 (2005) S10-S18
4. Marsh M.N. Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 102 (1992) 330-354
5. Pena A.S., and Wijmenga C. Genetic factors underlying gluten-sensitive enteropathy. Curr Allergy Asthma Rep 1 (2001) 526-533
6. Spurkland A., Sollid L.M., Polanco I., et al. HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. Hum Immunol 35 (1992) 188-192
7. Zubillaga P., Vidales M.C., Zubillaga I., et al. HLA-DQA1 and HLA-DQB1 genetic markers and clinical presentation in celiac disease. J Pediatr Gastroenterol Nutr 34 (2002) 548-554
8. Bevan S., Popat S., Braegger C.P., et al. Contribution of the MHC region to the familial risk of coeliac disease. J Med Genet 36 (1999) 687-690
9. Sollid L.M., and Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 105 (1993) 910-922
10. Greco L., Corazza G., Babron M.C., et al. Genome search in celiac disease. Am J Hum Genet 62 (1998) 669-675
11. Greco L., Babron M.C., Corazza G.R., et al. Existence of a genetic risk factor on chromosome 5q in Italian coeliac disease families. Ann Hum Genet 65 Pt 1 (2001) 35-41
12. Percopo S., Babron M.C., Whalen M., et al. Saturation of the 5q31-q33 candidate region for coeliac disease. Ann Hum Genet 67 Pt 3 (2003) 265-268
13. van Belzen M.J., Meijer J.W., Sandkuijl L.A., et al. A major non-HLA locus in celiac disease maps to chromosome 19. Gastroenterology 125 (2003) 1032-1041
14. van Belzen M.J., Vrolijk M.M., Meijer J.W., et al. A genomewide screen in a four-generation Dutch family with celiac disease: evidence for linkage to chromosomes 6 and 9. Am J Gastroenterol 99 (2004) 466-471
15. Monsuur A.J., de Bakker P.I., Alizadeh B.Z., et al. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 37 (2005) 1341-1344
16. Wahab P.J., Meijer J.W., and Mulder C.J. Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. Am J Clin Pathol 118 (2002) 459-463
17. Abdulkarim A.S., Burgart L.J., See J., et al. Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol 97 (2002) 2016-2021
18. Biagi F., and Corazza G.R. Defining gluten refractory enteropathy. Eur J Gastroenterol Hepatol 13 (2001) 561-565
19. Daum S., Cellier C., and Mulder C.J. Refractory coeliac disease. Best Pract Res Clin Gastroenterol 19 (2005) 413-424
20. Mulder C.J., Wahab P.J., Moshaver B., et al. Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma. Scand J Gastroenterol Suppl 232 (2000) 32-37
21. Wahab P.J., Meijer J.W., Goerres M.S., et al. Coeliac disease: changing views on gluten-sensitive enteropathy. Scand J Gastroenterol Suppl 236 (2002) 60-65
22. Cellier C., Delabesse E., Helmer C., et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma: French Coeliac Disease Study Group. Lancet 356 (2000) 203-208
23. Al Toma A., Verbeek W.H.M., and Mulder C.J. Survival in patients with refractory coeliac disease and enteropathy associated T cell lymphoma. Gut 56 (2007) 1373-1378
24. Meijer J.W., Mulder C.J., Goerres M.G., et al. Coeliac disease and (extra)intestinal T-cell lymphomas: definition, diagnosis and treatment. Scand J Gastroenterol Suppl 241 (2004) 78-84
25. Al Toma A., Goerres M.S., Meijer J.W., et al. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin Gastroenterol Hepatol 4 (2006) 315-319
26. Al Toma A., Verbeek W.H.M., and Visser O.J. Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma. Dig Liver Dis 39 (2007) 634-641
27. When is a coeliac a coeliac?. report of a working group of the United European Gastroenterology Week in Amsterdam, 2001. Eur J Gastroenterol Hepatol 13 (2001) 1123-1128
28. van Bodegraven A.A., Curley C.R., Hunt K.A., et al. Genetic variation in myosin IXB is associated with ulcerative colitis. Gastroenterology 131 (2006) 1768-1774
29. O'Mahony S., Howdle P.D., and Losowsky M.S. Review article: management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther 10 (1996) 671-680
30. Carrington M., Miller T., White M., et al. Typing of HLA-DQA1 and DQB1 using DNA single-strand conformation polymorphism. Hum Immunol 33 (1992) 208-212
31. Csizmadia C.G., Mearin M.L., Oren A., et al. Accuracy and cost-effectiveness of a new strategy to screen for celiac disease in children with Down syndrome. J Pediatr 137 (2000) 756-761
32. Verduyn W., Doxiadis II, Anholts J., et al. Biotinylated DRB sequence-specific oligonucleotides: comparison to serologic HLA-DR typing of organ donors in eurotransplant. Hum Immunol 37 (1993) 59-67
33. The International HapMap Project. Nature 426 (2003) 789-796
34. Barrett J.C., Fry B., Maller J., et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
35. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25 (2003) 115-121
36. Haldane J.B. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 20 (1956) 309-311
37. Bodegraven A.A., Curley C.R., Hunt K., et al. Genetic variation in myosin IXB is associated with ulcerative colitis. Gastroenterology 131 (2006) 1768-1774
38. Nunez C., Marquez A., Varade J., et al. No evidence of association of the MYO9B polymorphisms with celiac disease in the Spanish population. Tissue Antigens 68 (2006) 489-492
39. Giordano M., Marano C., Mellai M., et al. A family-based study does not confirm the association of MYO9B with celiac disease in the Italian population. Genes Immun 7 (2006) 606-608
40. Amundsen S.S., Monsuur A.J., Wapenaar M.C., et al. Association analysis of MYO9B gene polymorphisms with celiac disease in a Swedish/Norwegian cohort. Hum Immunol 67 (2006) 341-345
41. Sanchez E., Alizadeh B.Z., Valdigem G., et al. MYO9B gene polymorphisms are associated with autoimmune diseases in Spanish population. Hum Immunol 68 (2007) 610-615
42. Ogura Y., Bonen D.K., Inohara N., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
43. Hugot J.P., Chamaillard M., Zouali H., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
44. Hampe J., Cuthbert A., Croucher P.J., et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357 (2001) 1925-1928
45. Stoll M., Corneliussen B., Costello C.M., et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 36 (2004) 476-480
46. Gao M., Cao Q., Luo L.H., et al. [NOD2/CARD15 gene polymorphisms and susceptibility to Crohn's disease in Chinese Han population]. Zhonghua Nei Ke Za Zhi 44 (2005) 210-212
47. Karban A., Waterman M., Panhuysen C.I., et al. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease. Am J Gastroenterol 99 (2004) 1134-1140
48. Nagy Z., Karadi O., Rumi G., et al. Crohn's disease is associated with polymorphism of CARD15/NOD2 gene in a Hungarian population. Ann N Y Acad Sci 1051 (2005) 45-51
49. Buning C., Molnar T., Nagy F., et al. NOD2/CARD15 gene polymorphism in patients with inflammatory bowel disease: is Hungary different?. World J Gastroenterol 11 (2005) 407-411
50. Cavanaugh J. NOD2: ethnic and geographic differences. World J Gastroenterol 12 (2006) 3673-3677
51. Pearce A.V., Fisher S.A., Prescott N.J., et al. Investigation of association of the DLG5 gene with phenotypes of inflammatory bowel disease in the British population. Int J Colorectal Dis 22 (2007) 419-424
52. Noble C.L., Nimmo E.R., Drummond H., et al. DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population. Gut 54 (2005) 1416-1420
53. Buning C., Geerdts L., Fiedler T., et al. DLG5 variants in inflammatory bowel disease. Am J Gastroenterol 101 (2006) 786-792
54. Noble C.L., Nimmo E.R., Drummond H., et al. The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease. Gastroenterology 129 (2005) 1854-1864
55. Patey-Mariaud De S.N., Cellier C., Jabri B., et al. Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method. Histopathology 37 (2000) 70-77
56. Bagdi E., Diss T.C., Munson P., et al. Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood 94 (1999) 260-264
57. Murray A., Cuevas E.C., Jones D.B., et al. Study of the immunohistochemistry and T cell clonality of enteropathy-associated T cell lymphoma. Am J Pathol 146 (1995) 509-519